Sernova Corp.
TSX:SVA.TO · Toronto Stock Exchange
-$0.01 today
Vol 0.39M · Avg 0.12M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
62.8%
avg -56.2%
ROIC
192.9%
avg -42.0%
ROA
-2060.0%
avg -290.2%
Analysis
ROIC is currently the strongest return metric at 192.9% versus its period average of -42.0%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Jonathan N. Rigby | President, CEO & Director | $980,613.00 | — | 58 | — | — |
Marylyn Rigby | Chief Communications Officer | $521,125.00 | — | — | — | — |
James T. Parsons | Chief Financial Officer | $471,900.00 | — | 61 | — | — |
Pericles Calias | Chief Development Officer and Head of R&D | $336,296.00 | — | 58 | — | — |
David Burke | Vice President of Investor Relations | $163,151.00 | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
Covalon Technologies Ltd.
COV.V
$62.14M
Theralase Technologies Inc.
TLT.V
$59.12M
Leef Brands Inc.
LEEF.CN
$50.40M
MedMira Inc.
MIR.V
$45.61M
Microbix Biosystems Inc.
MBX.TO
$41.25M
Resverlogix Corp.
RVX.TO
$31.70M
Defence Therapeutics Inc.
DTC.CN
$26.96M
The Cannabist Company Holdings Inc.
CBST.NE
$17.47M
Hemostemix Inc.
HEM.V
$9.89M
BriaCell Therapeutics Corp.
BCT.TO
$7.70M
Who manages SVA.TO?
Sernova Corp. (SVA.TO) lists 5 active executives. The top listed executive is Marylyn Rigby, Chief Communications Officer.
Explore More
Continue the stock analysis
Jump to another research area for this company.